Clinical Trial Update: Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GPC 100 and Propranolol, with and without G-CSF, for mobilizing stem cells in multiple myeloma patients undergoing autologous stem cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Filgrastim (filgrastim)
• GPC 100
• Propranolol (propranolol)

Snippet

Sponsor: GPCR Therapeutics, Inc. | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED